As detailed in Table 1, high IL-1β levels measured shortly after stroke correlate with markedly poorer clinical outcomes and higher scores on the NIHSS, indicating a more severe degree of neurological damage [30]. The gene discussed is IL1B; the disease is stroke disorder.